|
Market Closed -
Bombay S.E.
06:02:22 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 431.75 INR | +1.07% |
|
+0.79% | +4.83% |
| 08-03 | Aarti Drugs Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | Aarti Drugs Limited Announces Management Changes | CI |
| Market Cap | 39.41B 411M 358M 338M 307M 575M 578M 4.05B 1.56B 20.03B 1.54B 1.51B 64.46B | P/E 2027 * |
-
| P/E 2028 * | 15.5x |
|---|---|---|---|---|---|
| Enterprise Value | 39.41B 411M 358M 338M 307M 575M 578M 4.05B 1.56B 20.03B 1.54B 1.51B 64.46B | EV / Sales 2027 * |
1.34x | EV / Sales 2028 * | 1.21x |
| Free-Float |
40.44% | Yield 2027 * |
1.37% | Yield 2028 * | 1.62% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| AARTIDRUGS | Delayed | |
NSE India S.E.
| AARTIDRUGS | Delayed |
Last Transcript: Aarti Drugs Limited
| 22-12-28 | Aarti Drugs : Loss of Share Certificates | PU |
| 22-07-10 | Aarti Drugs : Newspaper Advertisements | PU |
| 1 day | +1.07% | ||
| 1 week | +0.79% | ||
| Current month | +4.55% | ||
| 1 month | +4.44% | ||
| 3 months | +16.61% | ||
| 6 months | +26.59% | ||
| Current year | +4.83% |
| 1 week | 410.2 |  | 439.7 |
| 1 month | 409.95 | | 443.95 |
| Current year | 318.6 | | 453.2 |
| 1 year | 318.6 | | 533.6 |
| 3 years | 312.5 | | 634.9 |
| 5 years | 310.8 | | 648 |
| 10 years | 104.82 | | 1,025 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 80 | - | |
| Chief Executive Officer | 79 | 2007-05-31 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 43 | 2012-07-05 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 79 | 2014-03-31 | |
| Director/Board Member | 62 | 2007-05-31 | |
| Chairman | 80 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.07% | +0.79% | -16.36% | -27.18% | 411M | |
| +0.04% | +3.34% | +51.12% | +101.82% | 1,028B | |
| -0.09% | +1.66% | +55.02% | +66.18% | 651B | |
| -0.02% | +2.66% | +18.91% | +71.47% | 466B | |
| -1.22% | +3.66% | +36.44% | +38.32% | 346B | |
| -0.79% | +2.73% | +19.03% | +25.08% | 266B | |
| +0.58% | +6.76% | +11.13% | +16.52% | 259B | |
| +1.55% | +2.20% | +39.81% | +46.55% | 208B | |
| +0.79% | +1.84% | -28.27% | -56.71% | 191B | |
| -0.52% | +4.45% | +32.12% | +98.51% | 186B | |
| Average | +0.29% | +3.01% | +21.90% | +38.05% | 360.21B | |
| Weighted average by Cap. | +0.23% | +3.09% | +35.14% | +61.75% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 29.45B 307M 268M 253M 229M 430M 432M 3.03B 1.17B 14.97B 1.15B 1.13B 48.18B | 32.69B 341M 297M 280M 255M 477M 479M 3.36B 1.3B 16.62B 1.28B 1.25B 53.47B |
| Net income | 2.15B 22.43M 19.56M 18.47M 16.77M 31.42M 31.55M 221M 85.36M 1.09B 84.25M 82.38M 3.52B | 2.55B 26.53M 23.14M 21.85M 19.84M 37.17M 37.32M 262M 101M 1.29B 99.67M 97.46M 4.16B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | ₹431.75 | +1.07% | 5,081 |
| 26-09-17 | ₹427.20 | +0.75% | 7,343 |
| 26-09-16 | ₹424.00 | -0.67% | 8,255 |
| 26-09-15 | ₹426.85 | -0.35% | 8,497 |
| 26-09-11 | ₹428.35 | -1.95% | 8,713 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AARTIDRUGS Stock
Select your edition
All financial news and data tailored to specific country editions
